RGIYX
Price
$9.73
Change
+$0.06 (+0.62%)
Updated
Apr 2 closing price
Net Assets
345.2M
VCRVX
Price
$13.96
Change
+$0.09 (+0.65%)
Updated
Apr 2 closing price
Net Assets
876.15M
Ad is loading...

RGIYX vs VCRVX

Header iconRGIYX vs VCRVX Comparison
Open Charts RGIYX vs VCRVXBanner chart's image
Russell Inv Global Infrastructure Y
Price$9.73
Change+$0.06 (+0.62%)
VolumeN/A
Net Assets345.2M
NYLI CBRE Global Infrastructure Inv Cl
Price$13.96
Change+$0.09 (+0.65%)
VolumeN/A
Net Assets876.15M
RGIYX vs VCRVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGIYX vs. VCRVX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGIYX is a Buy and VCRVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VCRVX has more cash in the bank: 876M vs. RGIYX (345M). RGIYX pays higher dividends than VCRVX: RGIYX (3.07) vs VCRVX (1.48). RGIYX was incepted earlier than VCRVX: RGIYX (15 years) vs VCRVX (5 years). VCRVX (1.35) is less costly to investors than RGIYX (1.04). RGIYX is a more actively managed with annual turnover of: 67.00 vs. VCRVX (47.00). VCRVX has a lower initial minimum investment than RGIYX: VCRVX (1000) vs RGIYX (10000000). VCRVX annual gain was more profitable for investors over the last year : 16.42 vs. RGIYX (15.37). VCRVX return over 5 years is better than : 62.41 vs. RGIYX (44.23).
RGIYXVCRVXRGIYX / VCRVX
Total Expense Ratio0.831.3561%
Annual Report Gross Expense Ratio1.041.3577%
Fund Existence15 years5 years-
Gain YTD7.7607.309106%
Front LoadN/A6%-
Min. Initial Investment1000000010001,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets345M876M39%
Annual Yield % from dividends3.071.48207%
Returns for 1 year15.3716.4294%
Returns for 3 years9.366.92135%
Returns for 5 years44.2362.4171%
Returns for 10 years-7.45N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMMEX15.22N/A
N/A
Northern Active M Emerging Market Equity
SHPAX19.27N/A
N/A
Saratoga Health & Biotechnology A
GMXAX14.97N/A
N/A
Nationwide Mid Cap Market Idx A
SIEMX11.32N/A
N/A
SEI Emerging Markets Equity F (SIT)
JHDRX18.17N/A
N/A
JPMorgan Hedged Equity 2 R6